What Do DAWN Fundamentals Tell Options Traders?
Day One Biopharmaceuticals, Inc. (DAWN), operates in Healthcare / Biotechnology, listed on NASDAQ.
The fundamentals on this page cover the most recent annual income statement and trailing-twelve-month (TTM) profitability, leverage, and capital-efficiency ratios. Options traders use fundamentals to size position risk, choose between premium-selling and premium-buying structures, and frame the implied-volatility expectations going into earnings windows. Data refreshes once per trading day from the financial-statements feed; ratios are computed TTM rather than annualized so they reflect the most recent four reported quarters.
Income Statement (Latest Annual)
- Revenue
- $158.2M
- Net Income
- -$107.3M
- EPS
- -1.04
- Gross Profit Margin
- 89.1%
TTM Ratios
- P/E
- -20.74
- P/S
- 14.06
- P/B
- 5.05
- ROE
- -23.4%
- ROA
- -21.1%
- Debt/Equity
- 0.01
- Current Ratio
- 8.02
Key Metrics
- ROIC
- -28.0%
Reading the Numbers
DAWN shows negative trailing earnings (P/E -20.74), negative ROE, light leverage (debt-to-equity 0.01).
For options strategy selection, the trailing P/E and earnings trajectory frame the implied-volatility expectations going into earnings: a high-multiple growth profile typically commands richer pre-earnings IV (and a sharper post-event IV crush) than a low-multiple profile with stable earnings. Leverage and liquidity ratios influence the tail-risk profile relevant to put-selling and assignment risk; balance-sheet strength reduces the structural drift toward distress that can blow out short-put trades during a regime shift.
How Fundamentals Inform Options Strategy Selection
Options traders read fundamentals as one input to strategy selection rather than as a standalone directional thesis. Companies with positive free cash flow, contained leverage, and durable ROE are candidates for cash-secured put selling and covered-call income strategies, where assignment risk is backstopped by the underlying business. Companies with deteriorating fundamentals or elevated leverage are better paired with defined-risk structures (debit spreads, ratio backspreads) where maximum loss is capped at the cost of the premium paid.
Earnings catalysts deserve specific attention: high-multiple names with rising IV ahead of a print compress hard on a print that confirms the multiple, and they sell off sharply on a miss. That asymmetry is what makes pre-earnings short-vol structures attractive when IV rank is high and the company has a beat-rate track record, and dangerous when expectations are stretched. Pair the fundamental read with IV crush mechanics, the variance risk premium, and DAWN's earnings history before sizing into an event-driven trade.
Learn how fundamentals is reported and how to read the data →